Muhammad Zaheer Abbas
Submission to the Australian Parliament’s Joint Committee on Law Enforcement
Inquiry into Vaccine Related Fraud and Security Risks
EXECUTIVE SUMMARY:
Australia needs to support the proposal of temporarily waiving intellectual property protections to scale up production and supply of vaccines and other COVID-19 related treatments and diagnostics. The Brand-name pharmaceutical industry’s claim that the proposed TRIPS waiver will result in the proliferation of counterfeit vaccines and treatments is not supported by empirical evidence. There is no empirical evidence to suggest that prior to the adoption of the TRIPS Agreement the western markets were flooded with counterfeit drugs and vaccines manufactured by generic manufacturers. If there is a tangible risk of counterfeit vaccines, governments have mechanisms in place to curb any malpractices. Governments can further strengthen their existing mechanisms to deal with any issues hypothetically raised by brand-name pharmaceutical industry.
Click here for the full submission.
QUT Media4th November 2025 The United Kingdom Parliament is considering a bill aimed at making smoking obsolete, which has been
Speaking at the Global Expert Network on Copyright User Rights Symposium on 16 June 2025, Professor Christophe Geiger argues for
On 25 September 2025, Professor Wend Wendland, delivered the 14th Peter Jaszi Distinguished Lecture at American University in Washington D.C..
On September 18, 2025, the Italian Senate definitively approved the country’s first comprehensive framework law on artificial intelligence (AI). The
Por Andrés Izquierdo Durante la segunda semana de agosto, fui invitado a hablar en la Feria Internacional del Libro de
By Andrés Izquierdo AI, Copyright, and the Future of Creativity: Notes from the Panama International Book FairDuring the second week